[Results of treatment of malignant granuloma with Natulan Roche].
D000970:Antineoplastic Agents / Q000627:therapeutic use*; D006689:Hodgkin Disease / Q000188:drug therapy*; D006801:Humans; D006834:Hydrazines / Q000627:therapeutic use*; D014747:Vinblastine / Q000627:therapeutic use*
D000970:Antineoplastic Agents; D006834:Hydrazines; D014747:Vinblastine
Wyniki leczenia ziarnicy złośliwej preparatem Natulan firmy Roche.